Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the safety and efficacy of levamlodipine besylate (2.5mg or
5mg) versus amlodipine maleate (5mg) in patients with mild to moderate essential
hypertension.